Multicenter Experience with FRED Jr Flow Re-Direction Endoluminal Device for Intracranial Aneurysms in Small Arteries

Date
2017
Author
Bendszus, M.
Kocer, N.
Baltacioglu, F.
Cekirge, S.
Saatci, I.
Islak, C.
Moehlenbruch, M. A.
Kizilkilic, O.
Killer-Oberpfalzer, M.
Metadata
Show full item record
Abstract
The authors assessed the clinical safety and efficacy of the Flow Re-Direction Endoluminal Device Jr (FRED Jr) dedicated to small-vessel diameters between 2.0 and 3.0 mm in 42 patients with 47 aneurysms. The primary efficacy end point of complete or near complete occlusion was reached at 1 month in 27/41 (66%), at 6 months in 21/27 (78%), and at 12 months in 11/11 (100%) aneurysms.
URI
http://hdl.handle.net/20.500.12627/6417
https://doi.org/10.3174/ajnr.a5332
Collections